Bio-Techne TECH Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.21B+0.2% | $1.22B+1.6% | $1.22B+3.9% | $1.22B+5.2% | $1.21B+4.7% | ||
| $424.32M+2.5% | $422.82M+2.8% | $421.37M+4.3% | $429.36M+10.3% | $413.96M+8.0% | ||
| $786.49M-1.0% | $792.76M+1.0% | $795.37M+3.6% | $790.27M+2.7% | $794.81M+3.1% | ||
| 65%-0.8pp | 65.2%-0.4pp | 65.4%-0.1pp | 64.8%-1.6pp | 65.8%-1.0pp | ||
| $96.85M-0.6% | $97.98M-0.7% | $99.87M+3.5% | $99.5M+2.9% | $97.45M+1.4% | ||
| $535.88M+2.0% | $577.81M+18.9% | $585.57M+21.9% | $588.52M+26.2% | $525.42M+25.2% | ||
| $632.74M+1.6% | $675.79M+15.6% | $685.44M+18.8% | $688.02M+22.2% | $622.87M+20.8% | ||
| $632.74M+1.6% | $675.79M+15.6% | $685.44M+18.8% | $688.02M+22.2% | $622.87M+20.8% | ||
| —— | —— | —— | —— | $171.94M-32.7% | ||
| —— | —— | —— | $8.51M-45.9% | $10.32M-29.4% | ||
| —— | —— | —— | $3.89M+16.9% | $3.75M+12.0% | ||
| —— | —— | —— | —— | -$8.96M— | ||
| —— | —— | —— | —— | $162.98M-29.9% | ||
| —— | —— | —— | —— | $31.32M+6.7% | ||
| —— | —— | —— | —— | $131.67M-35.1% | ||
| —— | —— | —— | —— | $0.83-33.6% | ||
| —— | —— | —— | —— | $0.83-34.6% | ||
| 630.5M-1.7% | 632M-1.7% | 635.6M-1.1% | 640.4M-0.4% | 641.5M-0.4% | ||
| 625.2M-1.1% | 626.2M-0.9% | 628.8M-0.4% | 631.9M+0.2% | 632M+0.3% | ||
| —— | —— | —— | $3.89M+16.9% | $3.75M+12.0% | ||
| $124.76M-0.1% | $104.41M-23.3% | $73.68M-56.3% | $91.84M-41.1% | $124.92M-37.9% | ||
| -$3.32M+43.4% | -$4.87M-27.8% | -$4.2M+43.5% | -$5.57M-16.9% | -$5.86M-391% | ||
| $15.2M+325% | $23.31M+206% | -$4.31M-124% | $18.44M+250% | -$6.75M-284% | ||
| —— | —— | —— | $831K+110% | -$1.52M-128% | ||
| $96.85M-0.6% | $97.98M-0.7% | $99.87M+3.5% | $99.5M+2.9% | $97.45M+1.4% | ||
| $1.21B+0.2% | $1.22B+1.6% | $1.22B+3.9% | $1.22B+5.2% | $1.21B+4.7% | ||
| —— | —— | —— | —— | $171.94M-32.7% | ||
| —— | —— | —— | —— | $282.79M-22.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Techne's revenue?
- Bio-Techne (TECH) generated $1.2B in revenue over the trailing twelve months, up 0.2% year over year.
- Is Bio-Techne profitable?
- Bio-Techne reported $149.8M in net income over the trailing twelve months, a 10.9% net margin.
- What are Bio-Techne's profit margins?
- Gross margin is 65.0% and operating margin is 14.2%, with a 10.9% net margin.
- What is Bio-Techne's earnings per share?
- Bio-Techne's diluted EPS over the trailing twelve months is $0.94.
- Where does Bio-Techne's income statement data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
